Ed van Veen

With a visionary perspective, Ed van Veen addresses the intricate interplay between the nervous system and cancer, carving a niche in the field of cancer therapeutics. As an Adjunct Assistant Professor in the Department of Integrative Biology and Physiology at the University of California, Los Angeles, he brings a wealth of knowledge and expertise to his research endeavors. Ed's academic journey began with a B.S. in genetics and applied mathematics from UC Davis, followed by a Ph.D. in molecular biology from the Massachusetts Institute of Technology (MIT). Ed's research is primarily centered on understanding the complex interactions between the nervous system and cancer, with a particular focus on the side effects of cancer treatments. His work on tamoxifen-induced hot flashes, a prevalent issue faced by breast cancer patients, is groundbreaking. By investigating the underlying mechanisms of temperature dysregulation and hypothalamic involvement, Ed aims to develop adjuvant therapies that enhance patient compliance and improve overall quality of life. His dedication to unraveling the mysteries of the nervous system's role in cancer has led to significant advancements in the field. Ed's research not only contributes to the scientific community but also holds promise for tangible improvements in patient care. His work is characterized by a commitment to interdisciplinary collaboration, drawing insights from various fields to address complex biomedical challenges. Ed van Veen's contributions extend beyond the laboratory, as he actively engages with students and colleagues, fostering an environment of innovation and critical thinking. His passion for teaching and mentorship is evident in his interactions with aspiring scientists, whom he inspires to pursue their own research interests with rigor and curiosity. In addition to his academic pursuits, Ed is an advocate for bridging the gap between scientific research and clinical application. He believes in the potential of translational research to transform theoretical findings into practical solutions that benefit patients directly. Through his work, Ed continues to push the boundaries of what is known about the nervous system's involvement in cancer, paving the way for new therapeutic strategies and improved patient outcomes.